ABM-2697

N/A

Report date: 2023/09/25 17:59:18

NME

Base Information

Drug NameABM-2697

Drug Alias NameABM-2697

ClassificationSmall molecules

Mechanisms of ActionProtein kinases inhibitors

TargetsProtein kinases

Therapy Area/IndicationsLiver Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesABM Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesABM Therapeutics

Inactive CompaniesN/A

Active IndicationsLiver Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A